Skip to main content
OpenTrials
Completed

NCT Number: NCT00335114

Efficacy of Cyclosporine Ophthalmic Emulsion in the Treatment of Dry Eye Syndrome in Contact Lens Wearers

Cyclosporine Ophthalmic Emulsion is currently used in the treatment of dry eye syndrome. Contact lens wearers frequently suffer from dry eye syndrome. The purpose of this study is to evaluate cyclosporine ophthalmic emulsion verses re-wetting drops in the relief of dry eye symptoms in contact lens wearers

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Contact Lens Wearers With Dry Eye Syndrome Dry Eye Syndromes Eye Diseases Lacrimal Apparatus Diseases

Age range

19 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

UAB Ophthalmology Services Foundation

Birmingham, Alabama, 35233, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • contact lens wearer
  • clinical diagnosis of dry eye syndrome

Exclusion criteria

-

Treatment and study plan

cyclosporine ophthalmic emulsion

Drug

Primary outcomes

  1. Ocular exams and questionnaires at baseline and at 3 months will determine

  2. the effect of cyclosporine on dry eye syndrome.

Secondary outcomes

  1. Increased contact lens wearing time due to a decrease in severity

  2. of dry eye symptoms

Sponsors and collaborators

Lead sponsor

University of Alabama at Birmingham

Other

Registry information

Important dates

Study start
2005
Study completion
2006
First posted
Jun 8, 2006
Registry last updated
May 9, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.